InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Alter Jeffrey D., Director. Officer active across 3 companies, notably PROGENITY, INC.. Aggregated, 5 disclosures have been published. The latest transaction was disclosed on 15 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
096,154 shares0
Common Stock
SEC:0000899243-22-023091:0·
€101,010311 shares@ €324.7922100.0% of flow
Common Stock
SEC:0001156039-21-000086·
€101,010311 shares@ €324.792250.0% of flow
Common Stock
SEC:0001156039-21-000086:0·
029,183 shares0
Common Stock
SEC:0000899243-21-024202·
029,183 shares0
Common Stock
SEC:0000899243-21-024202:0·
5 of 5 declarations
About Alter Jeffrey D.
Jeffrey D. Alter is a Board Member and EVP, IngenioRx & Anthem Health, involved with several companies including PROGENITY, INC., Anthem, Inc., and BIORA THERAPEUTICS, INC. He plays a key role in strategic direction and operational oversight, bringing his expertise in the healthcare sector.
